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During a toxologic study of gold compounds, it was noted that the survivors 
of midlethal dose of goldthioglucose gained weight excessively. About one-third 
of the mice became obese (1).  Subsequent studies established that goldthio- 
glucose produced lesions  in the hypothalamus (2).  Other gold compounds of 
closely  related general structure,  such as  goldthiomalate, failed to  produce 
either the hypothalamic lesions or the obesity (2-4).  Goldthioglucose  obesity 
appeared to be of the hypothalamic variety which can be produced both in 
rats and mice by stereotactic injury to the ventromedial hypothalamic nuclei 
(S, 6). 
The apparent specificity of goldthioglucose  in producing lesions in the hy- 
pothalamus was ascribed to a particular affinity of the gold compound for the 
ventromedial nucleus, which has been identified as  the satiety center. This 
interpretation supported the glucostatic theory of regulation of food intake 
which asserted that the cells of the ventromedial nucleus are sensitive  to an 
increasing arterio-venous  difference in  blood  glucose.  High  blood  levels  of 
glucose would load the special receptor cells with glucose and activate discharge 
of impulses  inhibiting further food intake. The presumed selectivity of gold- 
thioglucose for the ventromedial nucleus was ascribed to the special affinity of 
these specialized nerve cells for the glucose moiety (4). 
Recently, the specific affinity of the hypothalamic center for goldthioglucose 
was investigated by quantitative measurement and localization  of the gold. 
This was made possible  by activation analysis capable of detecting gold in 
tissues in micromicrogram quantities and by use of radioautography for locali- 
zation (7, 8). The results clearly indicated that the obese animals had a higher 
concentration of gold in the hypothalamic area than similarly injected animals 
that had not become obese. It was, however, not possible to decide unequivocally 
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whether more gold had been attracted initially to the hypothalamus. The alter- 
native  had  to be  considered:  that  the  hypothalamic  lesion  itself  resulted  in 
greater  retention  of the initially  uniformly distributed  compound.  Moreover, 
accumulations  of gold  could be  demonstrated  not  only in  the  hypothalamic 
region, but also in other areas, confirming earlier evidence of extrahypothalamic 
lesions  due  to goldthioglucose  (9).  Finally,  our investigations  indicated  that, 
contrary  to  some  earlier  statements,  the  final  lesion  produced  by  goldthio- 
glucose is a fine glial scar and not merely a reduction in the number of neurons 
as depicted in the  original report  of the  lesions.  Consequently,  the  goldthio- 
glucose lesion was reinvestigated with two purposes in mind.  First, we wished 
to trace the entire development from the initial large necrotic lesion to the very 
small final scar and secondly, it was hoped, by accurate mapping of the area 
involved,  to determine  whether  failure  of obesity  to  develop  in  most  of the 
survivors of a  midlethal dose was due to failure of goldthioglucose to produce 
the initial  lesion in two-thirds  of the animals  or whether  the development  of 
obesity depended on the extent  of the lesion and its location. 
Materials and Methods 
Swiss albino mice of the NII-I strain, weighing 17 to 20 gm, were injected intraperitoneally 
with 12.5 mg of goldthioglucose in 0.25 ml saline. This dose had been previously determined to 
kill 50 per cent of the animals within 1 to 3 days, with no late mortality ascribable to the gold 
compound. All animals were fasted  24 hours prior and 20 hours  after injection, since this 
management had, in our experience, reduced mortality. 
In a preliminary experiment, 10 mice surviving 24 honrs were killed for histologic studies. 
In the main experiment 230 animals were randomized and 200 injected. Ten animals each 
of the injected group were killed 1, 4, and 14 days after injection. Onday 76, theweight of the 
injected animals varied from 24 to 48, and that of the 30 controls from 24 to 29 gm. Three 
controls and  15 of the injected  animals were killed, representing  the entire  weight range. 
Subsequently, weights of the controls increased to a maximum of 31, and those of experimental 
animals to 57. On days 205, 222, 228, 236, and 253, 2 animals each were killed, 1 of each 
group weighing in excess of 40 gin, the other 32 gm or less. In 2 supplementary  experiments a 
total of 50 animals were injected and 2 each killed on days 3, 5, 7, 8, 9, 10, 11, 12, and 14. 
At autopsy, the calvarium was removed, but the brain was left in sit~ and fixed together 
with the base of the skull in Bouin's fixative. After fixation, the brain was gently removed, 
embedded in paraffin and serial sections of the midbrain cut at 7#. For visualization of the 
astroglia, an additional  group of mice was injected with goldthioglucose and killed 5 to 15 
days later. Fixation was by perfusion with Cajal's formaldehyde-ammonlum bromide. Frozen 
sections were stained  by Cajal's mercuric-gold technique  (10). 
RESULTS 
A  total of 50 brains were examined of animals that had been injected with 
goldthioglucose  1  to  14 days earlier.  Hypothalamic lesions were found in 49. 
This included 23 animals killed  1 day after injection,  9  animals killed 4  days 
after injection, 2 animals each killed 5, 7, 8, 9, 10, and 12 days after injection, 
and  5  animals  killed  14 days after  injection.  In  1  animal,  killed  1  day after 
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One day after injection, the hypothalamic lesions could usually be seen with 
the unaided eye or a  low magnifying lens in hematoxylin and eosin--stained 
sagittal sections as sharply circumscribed, symmetrical, pale, oval areas meas- 
uring 1  x  2 mm on either side of the ventral end of the third ventricle, often 
joined by a  narrow bridge of similar pallor. On microscopic examination, the 
lesions extended occasionally as far forward as the optic chiasm, and they were 
often present  in sections  taken through the paraventricular  and  supraoptic 
nuclei. They were always present at the levels of the ventromedial hypothalamic 
nuclei and of the premammillary nuclei  (Figs.  1 to 5).  The bilateral lesions 
were often confluent in the midline or joined by a somewhat narrower bridge 
crossing the third ventricle. Posteriorly, the involved areas merged into a single 
midline lesion which occasionally extended as far as the posterior part of the 
medial mammillary nucleus. Both on day 1 and day 4 after injection the lesion 
consisted of a sharply circumscribed area of necrosis without cellular reaction. 
In a few animals killed as early as 12 to 24 hours after injection, a small number 
of pyknotic nuclei were still recognizable in the necrotic area, but after 24 hours 
only uniformly pink-staining material was visible. Occasionally a larger vessel 
traversing the necrotic lesion remained intact. No cellular reaction was present 
at the edge of the lesion. Where the third ventricle was involved, the ependynm 
had  either  disappeared  or  the markedly pyknotic nuclei of ependymal cells 
were still visible. Seven days after injection, the lesion had transformed itself, 
as it were by collapse of the broad area of necrosis, into a narrow band on either 
side of the ventricle of deeply eosinophilic staining material. Presumably this 
shrinkage of the lesion was primarily due to loss of fluid and diffusible products 
of autolysis, since no cellular infiltration was present at the line of demarcation 
of the lesion (Fig. 6). During the next 3 days, small round or oval cells  in- 
filtrated the lesion concomitantly with further shrinkage of the lesion. In addi- 
tion to the microglia, fat-laden macrophages were present in varying numbers. 
Polymorphonuclear cells were seen only rarely (Fig. 7). By the 14th day after 
injection, cellular infiltration had again disappeared in 4  of the 5 brains ex- 
amined, and the lesions had been transformed into a narrow scar, with only a 
few of either the microglia or the lipid laden cells remaining (Fig. 10). Transec- 
tion, reduplication or herniation of the third ventricle was the only remaining 
indication of the substantial loss of brain tissue which was known to have oc- 
curred from the sequential examination of animals during the first few days 
after injection. The distortion of the normal configuration of the third ventricle 
and interruption of its ependymal lining was often visible only caudad to the 
ventromedial nucleus, while at  the level of the nucleus itself no lesion was 
discernible  in  hematoxylin and  eosin-stained sections  (Figs.  8  and  9).  The 
relative lack of residual anatomic distortion at the level of the ventromedial 
nucleus and the greater residual damage in the posterior hypothalamic area 
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tension of the lesion is not at the level of the ventromedial nucleus. This is 
supported by careful mapping of the acute lesion. As may be seen from Fig. 1, 
the  ventromedial nucleus  may be  largely spared  even  though  the  necrotic 
lesion  extends  considerably ventrally,  laterally,  and  caudally. 
Of the 8 animals examined 76 days after injection, scars of the type just 
described were demonstrable in all. Only 1 still had some celhflar infiltration 
in the involved area  (Fig.  11). There was a  distinct tendency for the obese 
animals, weighing in excess of 35 gm, to have more scarring than those with 
weights in the normal, i.e. below 30 gm (Fig. 12). This tendency was confirmed 
in  the paired obese and non-obese animals examined 206  to  263  days after 
injection (Figs. 13 and 14). Indeed, in 2 non-obese injected animals examined 
228 and 263  days after injection, no scar was found. Scars were found in all 
obese animals. 
Animals killed 1 and 4 days after injection also had necrotic lesions in sites 
other than the hypothalamic area.  In the hippocampus,  symmetrical lesions 
were  occasionally present  extending from  the  midline  and  involving about 
one-third of the hippocampus (Fig. 15). In other animals only the hippocampal 
commissure was  involved.  Necrotic  lesions  were  also  found in  the  medulla 
oblongata  (Fig.  16).  These  localizations corresponded  to  those  reported  by 
Perry and Liebelt (11)  which had been found to be sites of concentration of 
gold-thioglucose in  brains  subjected  to  neutron  activation  and radioautog- 
raphy (7). These extrahypothalamic lesions have not been studied systemati- 
cally. However, their occurrence appeared to be less constant than the hypo- 
thalamic lesions, and when present they were quite variable in extent. In none of 
the lesions did the areas involved correspond to recognizable units of nuclei and 
tracts, e.g.  in the hippocampal commissure, an irregular area of white matter 
was often involved which clearly did not follow the distribution of commissural 
fibers.  The involvement of the hippocampus, when present, appeared to be a 
simple  extension  of  the  necrosis  of  the  hippocampal  commissure,  but  was 
restricted to the median third and again did not follow known fiber tracts. The 
only regularity discernible in all lesions was their symmetrical distribution. 
Brains perfused with  Cajal's calcium-bromide fixative, from which frozen 
sections were cut for silver impregnation, indicated a marked degree of gliosis 
at a  time when only a  negligible scar was visible in hematoxylin and eosin- 
stained sections. 
DISCUSSION 
The presence of hypothalamic lesions in 49 of 50 mice killed during the first 
2 weeks after goldthioglucose injection contrasts sharply with an incidence of 
only 30 per cent of clearcut obesity in the surviving animals. Obesity must 
therefore be correlated with the extent of the lesions,  rather than with their 
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initial necrotic lesion, which is not centered in the ventromedial nucleus. Rather, 
the symmetrical necrotic area, which extends for a considerable distance rostral 
and caudad, is centered ventrally to the ventromedial nuclei.  It may involve 
the nuclei only marginally or destroy them completely. Thus,  depending on 
the extent of the necrotic lesion, part or all of the nucleus on each side may be 
involved.  These  observations are  in  keeping  with  the  findings  of Liebelt et 
al.  (11) that in CAB mice low doses of goldthioglucose  produce small  lesions 
which are restricted to the acellular area between the arcuate and ventromedial 
nuclei. No obesity occurs in animals bearing these smaller lesions. 
From the experiments of Mayer et al. (6), using a stereotactic instrument, it 
appears that obesity develops only when the ventromedial nucleus is destroyed 
bilaterally. There is, however, no sharp line between obesity and normal weight 
gain and there are varying degrees of obesity among the mice which exceed the 
control weights. Whether  the minor degrees of obesity develop when the bi- 
lateral destruction of the nuclei falls short of being truly complete, or whether 
destruction of efferent tracts (12, 13) or other features of the lesions determine 
degrees  of obesity is  impossible  to  state  from  the  data  at  hand.  The  basic 
notion, however, that  the extent of the initial  necrotic lesion  determines the 
development of obesity is in accord with the known fact that obese animals have 
more prominent  scars  than  those within  the normal  weight range  and  that 
accumulation of gold in the radioautographs of the hypothalamus is prominent 
only in the obese animals  (7, 8). 
One of the puzzling features of the goldthioglucose lesions is their distribution. 
It has been suggested that  the localization  in the hypothalamus,  the hippo- 
campal  commissure and  the dorsal midbraln  denotes areas of a  deficient  or 
easily injured blood-brain barrier (9). The uniform distribution of gold through- 
out the brain at 1 hour after goldthioglucose  injection, as determined by acti- 
vation analysis, does not support this concept nor does the similar concentration 
obtainable with goldthiomalate  (7,  8,  14). A special  susceptibility of the hy- 
pothalamus and the other affected areas to damage by goldthioglucose  must 
still  be postulated to explain  the localization  of the lesion  and the failure of 
goldthiomalate to produce either lesions or obesity. It is tempting to think of 
special  chemoreceptors or a  distinct  metabolism in  the areas  involved  (14). 
Such a  mechanism has been postulated to explain  the sharply circumscribed 
lesions which can be produced in the hypothalamus and the pyramidal  layer 
of the hippocampus by 3-acetylpyridine and which can be prevented by nico- 
tinamide (15). The concept was supported by distinctive staining with dithizone 
and other indirect evidence.  Similarly,  focal neurologic  lesions were produced 
in dogs by  monoamine oxidase inhibitors (16). In both instances,  as in the case of 
goldthioglucose,  the lesions were reproducible only in 1 or 2 species of animals 
(16, 17). The areas involved in goldthioglucose  lesions may be postulated to be 
similarly distinctive. However, no relevant characterization of their metabolism 400  BRAIN LESION OF  GOLDTttIOGLUCOSE  OBESITY 
has been possible to date. In particular, the hypothalamic localization of  the 
lesions cannot be accounted for by a  specific affinity of the ventromedial nu- 
cleus for the glucose moiety, since this nucleus is frequently situated only at 
the margin and may be largely spared in the presence of a  clearcut hypotha- 
lamic lesion. 
The transformation of a relatively large initial necrotic lesion into a barely 
visible scar is one of the puzzling features of the goldthioglucose lesion. The 
occasionally complete disappearance of even this minute residuum may, how- 
ever, be more apparent than real. In brains fixed and stained by Cajal's method 
gliosis  was striking, and it is not unlikely that such preparations would have 
revealed the presence of a residual lesion in the rare cases in which hematoxylin 
and eosin-stained sections failed to do so. The reduction of the size of the lesion 
so that serial sections are needed for its demonstration presumably accounts 
for the failure to visualize the lesions in the original investigation of goldthio- 
glucose obesity  (1).  Apparently Marshall  et  al.  (2)  who  first  described  the 
acute  necrotic lesion,  also  failed to  observe the  residual  scar.  Their legend 
accompanying the illustration of the hypothalamus 3  months after injection 
describes a reduction in the number of cells in the ventromedial nucleus. It is 
now apparent that the initial necrotic lesion does not result in a mere reduction 
of nerve cells with preservation of the outline of the nucleus, but rather in a 
residual scar which was not visualized in the particular section illustrated. 
s~¥ 
The  development of  hypothalamic lesions  due  to  goldthioglucose are  de- 
scribed. The initial extensive necrotic lesion occurs in close to 100 per cent of 
animals  injected with  LI~60. Within  2  weeks  the  necrotic  material  has  been 
removed and a narrow scar results. After a lapse of several months, the scar is 
often  difficult  to  visualize,  especially  in  animals  that  have  not  developed 
obesity. The ventromedial nucleus is not the center of the lesion. The nucleus 
is preserved in some instances, and partially or completely destroyed in others, 
depending on the extent of the lesion. The more prominent scar in the obese 
animals  correlates with  the  larger  initial  lesion  necessary for  the  complete 
bilateral destruction of the ventromedial nucleus which is known to be a pre- 
requisite  for  the  development of  hypothalamic  obesity. 
Thus,  contrary  to  earlier  suggestions,  goldthioglucose  does  not  localize 
specifically in the  cells  of the ventromedial nucleus. 
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EXPLANATION OF  PLATES 
PLATES 28 AND 29 
FIGS. 1 to 5.  One day after injection of goldthioglucose.  Selected  serial sections of 
the same brain. The cuts illustrated in Figs. 2 to 5 are 0.8, 0.9. 1.3, and 1.5 mm caudad 
of that in Fig. 1. Symmetrical necrotic lesion extends from level of the paraventricular 
nuclei (pv) in Fig.  1 to  that of  the  mammillary body  (cm)  in Fig. 5.  Note partial 
preservation of ventromedial nuclei (vm), persistence of some pyknotic cells within 
the  necrotic areas,  and destruction of  the  ependymal lining of  the  third ventricle. 
pth, posterior thalamic nuclei,  f, fornix. Hematoxylin and eosin stain. ×  38. 
(Brecher et al.: Brain lesion of goldthioglucose  obesity) PLATE 30 
FIG. 6.  Seven days after goldthioglucose  injection. Collapse of  the necrotic area. 
Hematoxylin and eosin Stain.  X 38. 
Fzo.  7.  Ten days after goldthioglucose  injection. Infiltration of the collapsed  area 
by small round cells and foam cells. In this particular lesion polymorphonuclear cells 
are also present. Hematoxylin and eosin stain. ×  100. THE JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  30 
(Brecher et al. : Brain lesion of goldthioglucose obesity) PLATE 31 
FIG. 8.  Twelve days after goldthioglucose  injection. Note preservation of ventro- 
medial nucleus and absence of discernible lesion at this level. Hematoxylin and eosin 
stain. X  100. 
FIG.  9.  Section  of  same  brain,  immediately  caudad  to  ventromedial  nucleus. 
Obvious lesion: transection of  third ventricle presumably occasioned  by collapse  of 
initial necrotic lesion and developing scar.  Hematoxylin and eosin stain.  X  100. 
FIG. 10.  Fourteen days after goldthioglucose.  The symmetrical fine glial scar indi- 
cates the maximal extent of the residual lesion in this animal. Hematoxylin and eosin 
stain.  ×  100. TI~IE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  31 
(Brecher et al. : Brain lesion of goldthioglucose obesity) PLATE 32 
FIG.  11.  Seventy-six days after goldthioglucose.  Brain of  heaviest animal in the 
group (48 gm).  Some round cell infiltration still present in large scar.  Hematoxylin 
and eosin stain. X  100. 
FIG. 12,  Seventy-six days. Brain of animal weighing 24 gm. Minimal lesion. Hema- 
toxylin and Eosin stain.  X  100. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  32 
(Brecher et al.: Brain lesion of goldthioglucose obesity) PLATE 33 
FIG. 13.  Two hundred and forty-two days. Brain of animal weighing 55 gin. Scar 
distorting 3rd ventricle, Hematoxylin and eosin stain.  ×  100. 
FIG, 14.  Two hundred and forty-two days. Brain of animal weighing 28 gin. Dis- 
tortion of ventricle and probable gliosis in adjacent area is only indication of a residual 
lesion. Hematoxylin and eosin stain.  ×  100. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  33 
(Brecher et al. : Brain lesion of goldthioglucose obesity) PLATE 34 
FIG. 15.  One day  after  injection. Hippocampal necrotic  area.  ttematoxylin and 
and Eosin stain. ×  63. 
FIG. 16.  One day after goldthioglucose.  Necrotic area in the  medulla oblongata. 
Hematoxylin and eosin stain. X 63. THE JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  34 
(Brecher et al. : Brain lesion of goldthioglucose obesity) 